blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3147279

EP3147279 - CAROTENOID DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICALLY ACCEPTABLE ESTER OR AMIDE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.03.2024
Database last updated on 25.09.2024
FormerExamination is in progress
Status updated on  08.06.2020
FormerRequest for examination was made
Status updated on  24.02.2017
FormerThe international publication has been made
Status updated on  07.11.2016
Most recent event   Tooltip15.03.2024Application deemed to be withdrawnpublished on 17.04.2024  [2024/16]
Applicant(s)For all designated states
Fuji Chemical Industries Co., Ltd.
55, Yokohoonji
Kamiichi-machi
Nakaniikawa-gun, Toyama 930-0397 / JP
[2022/01]
Former [2018/40]For all designated states
Asta Pharmaceuticals Co., Ltd.
55, Yokohoonji
Kamiichi-machi
Nakaniikawa-gun
Toyama 930-0397 / JP
Former [2017/13]For all designated states
Fuji Chemical Industry Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun, Toyama 930-0397 / JP
Inventor(s)01 / FUJITA, Takashi
c/o Fuji Chemical Industries Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun Toyama 930-0397 / JP
02 / KOBAYASHI, Satoshi
c/o Fuji Chemical Industries Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun Toyama 930-0397 / JP
03 / SHINOHARA, Ryoma
c/o Fuji Chemical Industries Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun Toyama 930-0397 / JP
04 / NISHIDA, Yasuhiro
c/o Fuji Chemical Industries Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun Toyama 930-0397 / JP
05 / TAKAHASHI, Jiro
c/o Fuji Chemical Industries Co., Ltd.
55 Yokohoonji
Kamiichi-machi
Nakaniikawa-gun Toyama 930-0397 / JP
 [2017/13]
Representative(s)Blodig, Wolfgang
Wächtershäuser & Hartz
Patentanwaltspartnerschaft mbB
Weinstrasse 8
80333 München / DE
[2017/13]
Application number, filing date15795815.820.05.2015
[2017/13]
WO2015JP64408
Priority number, dateJP2014010448020.05.2014         Original published format: JP 2014104480
JP2014024754908.12.2014         Original published format: JP 2014247549
[2017/13]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015178404
Date:26.11.2015
Language:JA
[2015/47]
Type: A1 Application with search report 
No.:EP3147279
Date:29.03.2017
Language:EN
[2017/13]
Search report(s)International search report - published on:JP26.11.2015
(Supplementary) European search report - dispatched on:EP13.12.2017
ClassificationIPC:C07C403/24, A61K31/22, A61K31/27, A61K31/4178, A61P3/04, A61P3/06, A61P9/04, A61P9/12, A61P21/00, A61P25/18, A61P25/24, A61P25/28, A61P27/00, A61P27/02, A61P27/06, A61P29/00, A61P35/00, C07D233/61
[2017/13]
CPC:
C07D233/61 (EP,IL,KR,US); A61K31/22 (EP,IL,KR,US); C07C403/24 (EP,IL,KR,RU,US);
A61K31/27 (EP,IL,KR,RU,US); A61K31/4178 (EP,IL,KR,US); A61P21/00 (EP,RU);
A61P25/18 (EP,RU); A61P25/24 (EP,RU); A61P25/28 (EP,RU);
A61P27/00 (EP,RU); A61P27/02 (EP,RU); A61P27/04 (EP);
A61P27/06 (EP,RU); A61P29/00 (EP,RU); A61P3/00 (EP);
A61P3/04 (EP,RU); A61P3/06 (EP,RU); A61P3/10 (EP);
A61P35/00 (EP,RU); A61P39/06 (EP); A61P9/00 (EP);
A61P9/04 (EP,RU); A61P9/10 (EP); A61P9/12 (EP,RU) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/13]
TitleGerman:CAROTENOIDDERIVAT, PHARMAZEUTISCH UNBEDENKLICHES SALZ DAVON UND PHARMAZEUTISCH UNBEDENKLICHES ESTER UND AMID DAVON[2017/13]
English:CAROTENOID DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICALLY ACCEPTABLE ESTER OR AMIDE THEREOF[2017/13]
French:DÉRIVÉ DE CAROTÉNOÏDE, SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER ET ESTER OU AMIDE PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER[2017/13]
Entry into regional phase07.11.2016Translation filed 
07.11.2016National basic fee paid 
07.11.2016Search fee paid 
07.11.2016Designation fee(s) paid 
07.11.2016Examination fee paid 
Examination procedure07.11.2016Examination requested  [2017/13]
07.11.2016Date on which the examining division has become responsible
05.07.2018Amendment by applicant (claims and/or description)
12.06.2020Despatch of a communication from the examining division (Time limit: M04)
22.09.2020Reply to a communication from the examining division
01.12.2023Application deemed to be withdrawn, date of legal effect  [2024/16]
21.12.2023Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/16]
Fees paidRenewal fee
31.05.2017Renewal fee patent year 03
30.05.2018Renewal fee patent year 04
24.05.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
31.05.2021Renewal fee patent year 07
31.05.2022Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.202309   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption10.12.2020Interruption of proceedings. Reason: legal prevention of applicant[2021/42]
01.12.2021Resumption of proceedings[2021/42]
Documents cited:Search[I]WO2005102356  (HAWAII BIOTECH INC [US], et al);
 [I]WO2006099015  (HAWAII BIOTECH INC [US], et al);
 [I]WO2006105214  (HAWAII BIOTECH INC [US], et al);
 [I]WO2006119168  (HAWAII BIOTECH INC [US], et al);
 [I]WO2008106606  (CARDAX PHARMACEUTICALS INC [US], et al);
 [I]WO2008118862  (CARDAX PHARMACEUTICALS INC [US], et al);
International search[A]JP2005517010  ;
 [A]JP2006517197  ;
 [A]JP2007176814  (FUTAMURA YOSHIHIRO);
 [A]JP2010248243  (CARDAX PHARMACEUTICALS INC);
 [A]JP2013518856
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.